Department of Cellular and Physiological Sciences (M.S., L.A.H., C.M.U., G.L.H.), University of British Columbia, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver, British Columbia, Canada, V6T 1Z3; Department of Pathology and Laboratory Medicine (B.O.K.), University of British Columbia, Child and Family Research Institute, 950 W 28th Ave, Vancouver, British Columbia, Canada, V5Z 4H4; Department of Microbiology and Immunology (I.V.), University of British Columbia, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver, British Columbia, Canada, V6T 1Z3; and Department of Microbiology and Immunology (R.E.W.H.), University of British Columbia, Centre for Microbial Diseases and Immunity Research, 2259 Lower Mall Research Station, Vancouver, British Columbia, Canada, V6T 1Z4.
Endocrinology. 2014 Aug;155(8):2900-8. doi: 10.1210/en.2014-1055. Epub 2014 May 21.
The serine protease inhibitor (SERPIN) family member corticosteroid-binding globulin (CBG) is the main carrier of glucocorticoids in plasma. Human CBG mediates the targeted release of cortisol at sites of inflammation through cleavage of its reactive center loop (RCL) by neutrophil elastase. The RCLs of SERPIN family members are targeted by diverse endogenous and exogenous proteases, including several bacterial proteases. We tested different bacteria for their ability to secrete proteases that disrupt CBG cortisol-binding activity, and characterized the responsible protease and site of CBG cleavage. Serum CBG integrity was assessed by Western blotting and cortisol-binding capacity assay. Effects of time, pH, temperature, and protease inhibitors were tested. Proteolytically active proteins from bacterial media were purified by fast protein liquid chromatography, and the active protease and CBG cleavage sites were identified by mass spectrometry. Among the bacteria tested, medium from Pseudomonas aeruginosa actively disrupted the cortisol-binding activity of CBG. This proteolytic activity was inhibited by zinc chelators and occurred most efficiently at pH 7 and elevated physiological temperature (ie, 41°C). Mass spectrometric analysis of a semi-purified fraction of P. aeruginosa media identified the virulence factor LasB as the responsible protease, and this was confirmed by assaying media from LasB-deficient P. aeruginosa. This metalloprotease cleaves the CBG RCL at a major site, distinct from that targeted by neutrophil elastase. Our results suggest that humoral responses to P. aeruginosa infection are influenced by this pathogen's ability to secrete a protease that promotes the release of the anti-inflammatory steroid, cortisol, from its plasma transport protein.
丝氨酸蛋白酶抑制剂 (SERPIN) 家族成员皮质类固醇结合球蛋白 (CBG) 是血浆中糖皮质激素的主要载体。人类 CBG 通过中性粒细胞弹性蛋白酶切割其反应中心环 (RCL) 介导皮质醇在炎症部位的靶向释放。SERPIN 家族成员的 RCL 被多种内源性和外源性蛋白酶靶向,包括几种细菌蛋白酶。我们测试了不同细菌分泌破坏 CBG 皮质醇结合活性的蛋白酶的能力,并对负责的蛋白酶和 CBG 切割位点进行了表征。通过 Western blot 和皮质醇结合能力测定评估血清 CBG 完整性。测试了时间、pH 值、温度和蛋白酶抑制剂的影响。通过快速蛋白质液相色谱法纯化细菌培养基中的具有蛋白水解活性的蛋白质,并通过质谱鉴定活性蛋白酶和 CBG 切割位点。在测试的细菌中,铜绿假单胞菌培养基中的活性蛋白可积极破坏 CBG 的皮质醇结合活性。这种蛋白水解活性被锌螯合剂抑制,在 pH 值为 7 和升高的生理温度(即 41°C)下最有效。铜绿假单胞菌培养基的半纯化部分的质谱分析鉴定了毒力因子 LasB 为负责的蛋白酶,通过测定 LasB 缺陷型铜绿假单胞菌的培养基得到了证实。这种金属蛋白酶在一个主要位点切割 CBG 的 RCL,与中性粒细胞弹性蛋白酶的靶向位点不同。我们的结果表明,对铜绿假单胞菌感染的体液反应受到该病原体分泌一种蛋白酶的能力的影响,这种蛋白酶促进抗炎类固醇皮质醇从其血浆转运蛋白中释放。